Send us Feedback

OXiGENE (OXGN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
OXiGENE Announces Full Year 2011 Earnings Conference Call and Webcast
Globe Newswire  Mar 6  Comment 
SOUTH SAN FRANCISCO, Calif., March 6, 2012 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report full year 2011 results on Tuesday,
Biotech Sector Shows No Signs of Slowing -- OXiGENE and Generex Poised for Growth
Marketwire  Feb 7  Comment 
NEW YORK, NY -- (Marketwire) -- 02/07/12 -- Biotech stocks are on fire in 2012. The iShares NASDAQ Biotechnology index is up more than 15 percent year-to-date as impressive earnings results have boosted investor optimism in the industry. According to
Oxigene Spiking Higher on Heavy Volume
Benzinga  Jan 24  Comment 
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
OXiGENE (OXGN) Files 4.85M Common Shelf for Shareholder
StreetInsider.com  Dec 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/OXiGENE+%28OXGN%29+Files+4.85M+Common+Shelf+for+Shareholder/7039503.html for the full story.
Pre-Open Movers 12/12: (OXGN) (ENDP) (TPX) Higher; (DMND) (ONXX) (INTC) Lower (more...)
StreetInsider.com  Dec 12  Comment 
Below are stocks making major moves in pre-open trading Monday: HIGHER: OXiGENE, Inc. (Nasdaq: OXGN) 15% HIGHER; OXGN, Azanta Danmark Enter ZYBRESTAT Partnership in Europe, Canada Endo Pharma (Nasdaq: ENDP) 5% HIGHER; reports FDA approval for...
OXiGENE (OXGN), Azanta Danmark Enter ZYBRESTAT Partnership in Europe, Canada
StreetInsider.com  Dec 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/OXiGENE+%28OXGN%29%2C+Azanta+Danmark+Enter+ZYBRESTAT+Partnership+in+Europe%2C+Canada/7011217.html for the full story.
OXiGENE (OXGN) Reports ZYBRESTAT Missed Primary Objective in Favor Phase 2
StreetInsider.com  Dec 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/OXiGENE+%28OXGN%29+Reports+ZYBRESTAT+Missed+Primary+Objective+in+Favor+Phase+2/7001764.html for the full story.
OXiGENE Presents Data From FAVOR Study of ZYBRESTAT in PCV
Globe Newswire  Dec 7  Comment 
SOUTH SAN FRANCISCO, Calif., Dec. 7, 2011 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that Dr. Timothy Lai, MD, FRCS,
Morning Movers 11/28: (OXGN) (CMC) (VIT) (GMO) Higher; (CLSN) (WILC) Lower
StreetInsider.com  Nov 28  Comment 
OXiGENE, Inc. (Nasdaq: OXGN) 24.7% HIGHER; has signed a purchase agreement for the sale, from time to time, of up to $20 million of its common stock with Lincoln Park Capital Fund, LLC (LPC), a Chicago-based institutional investor. The proceeds...
OXiGENE (OXGN) Enters $20M Purchase Agreement with LPC
StreetInsider.com  Nov 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/OXiGENE+%28OXGN%29+Enters+%2420M+Purchase+Agreement+with+LPC/6976954.html for the full story.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/OXiGENE_(OXGN)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki